Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma

BACKGROUND: Many patients with classical Hodgkin lymphoma show increased programmed death-1 ligand expression in Reed–Sternberg cells. We report the final results of a phase II study of nivolumab, an anti-programmed death-1 monoclonal antibody, in Japanese patients with relapsed or refractory classi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Jpn J Clin Oncol
मुख्य लेखकों: Maruyama, Dai, Terui, Yasuhito, Yamamoto, Kazuhito, Fukuhara, Noriko, Choi, Ilseung, Kuroda, Junya, Ando, Kiyoshi, Hattori, Akira, Tobinai, Kensei
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2020
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7579338/
https://ncbi.nlm.nih.gov/pubmed/32776097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyaa117
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन